ELEDON PHARMACEUTICALS INC(NASDAQ:ELDN) stock News

ELDN Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host a Conference Call to Discuss Updated Data from the Ongoing Phase 1b Trial of Tegoprubart in Kidney Transplantation Being Presented at the World Transplant Congress 2025

8 days ago - By: Benzinga - Mentions: EXEL MLSS PTCT ADAP ...

12 Health Care Stocks Moving In Monday's After-Market Session

19 days ago - By: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

19 days ago - By: Eledon Pharmaceuticals, Inc.

Updated Data from Eledon Pharmaceuticals’ Ongoing Phase 1b Trial of Tegoprubart in Patients Undergoing Kidney Transplantation to be Presented at the World Transplant Congress 2025

a year ago - By: BusinessInsider

ELDN Stock Earnings: Eledon Pharma Misses EPS for Q2 2024

a year ago - By: InvestorPlace

ELDN Stock Earnings: Eledon Pharma Misses EPS for Q2 2024

a month ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

a month ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Host R&D Day on July 9, 2025 in New York City

2 months ago - By: Zacks Investment Research

What Makes Eledon Pharmaceuticals (ELDN) a New Buy Stock

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

3 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports First Quarter 2025 Operating and Financial Results

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Operating and Financial Results

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

5 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Leerink Partners Global Healthcare Conference

6 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

6 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Use of Tegoprubart as Key Component of Immunosuppression Regimen in its Second Transplant of a Genetically Modified Pig Kidney into a Human

6 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

6 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities SMID Cap Biotech Conference

7 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

7 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Highlights Recent Business Milestones and Provides 2025 Outlook

9 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

9 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Recent Business Highlights and Third Quarter 2024 Financial Results

9 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals to Participate in Guggenheim Securities Inaugural Healthcare Innovation Conference

9 months ago - By: Benzinga - Mentions: ATEC CORT ACHC ANIX ...

12 Health Care Stocks Moving In Wednesday's After-Market Session

9 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

9 months ago - By: Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals Announces Pricing of $85 Million Underwritten Offering of Common Stock and Pre-Funded Warrants

9 months ago - By: Eledon Pharmaceuticals, Inc.